Houston, Texas - OmniScience is pleased to announce that it is now a resident company of Johnson & Johnson’s global incubator network, JLABS.

Vivo - The First genAI Control Tower for Clinical Development Teams

OmniScience is the first and only company bringing agentic AI to clinical trials, redefining how teams analyze and interact with their data. Vivo, the world’s first genAI clinical trial control tower, delivers an AI-driven data analyst that provides real-time insights, proactive notifications, and explainable answers to accelerate decisions and detect trial issues early.

Vivo unifies trial data across all sources, enhancing study oversight and expediting closeout activities. Going beyond visualizations, Vivo delivers interactive patient profiles, actionable alerts, enrollment forecasting, and smart data management - all powered by an advanced cognitive architecture that combines ontological knowledge of trial protocols with domain-specific clinical expertise. These capabilities reduce delays, optimize workflows, and improve trial outcomes.

With 85% of clinical trials facing delays, the industry needs modern, AI-driven solutions. Vivo represents the future of clinical development, transforming outdated trial management into a proactive, intelligent system that ensures trials stay on track.

Accelerating Innovation Through JLABS

OmniScience’s residency at JLABS unlocks access to an expansive innovation ecosystem and invaluable mentorship. “Becoming part of JLABS enables us to refine Vivo and expand its capabilities to meet the evolving needs of clinical development teams,” said Angela Holmes, CEO of OmniScience. “We are excited to collaborate with world-class innovators who share our commitment to advancing patient outcomes and addressing the $80 billion annual cost of clinical trials through leading-edge solutions.”

JLABS is the largest global network of open innovation ecosystems, enabling and empowering emerging companies with the knowledge, experience, partnerships, and venture connections across a broad healthcare spectrum including pharmaceutical and medical technology sectors. More information: https://jlabs.jnjinnovation.com/

About OmniScience, Inc.

OmniScience is a trusted AI partner for leading life science teams, advancing clinical R&D through unparalleled expertise in clinical data science. We envision a future where clinical trial data is unified and transformed into real-time knowledge, enabling teams to make faster, more informed decisions.

With Vivo - the first and only agentic AI control tower for clinical trials - we provide on-demand insights into live, unified trial data. No spreadsheets, no SQL queries, no emails - just instant, explainable answers.

Vivo redefines how pharma manages clinical trials, introducing the industry’s first genAI assistant for trial operations. Vivo is an agentic AI platform, streamlining workflows, optimizing trial oversight, and empowering teams to harness genAI-driven intelligence for better, faster outcomes